Transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additive

US12214088B2 · kind B2 · utility

Assignees

• LTS Lohmann Therapie-Systeme AG · DE
• DDP Specialty Electronic Materials US, LLC. · US

Inventors

• Marco Emgenbroich · Neuss, DE
• Eva-Marie Prinz · Weißenthurm, DE
• Elke Klein · Bad Neuenahr-Ahrweiler, DE
• Heike Kluth · Ochtendung, DE
• Xavier Thomas · Sint-Genesius-Rode, BE
• Linda Sue Nartker · Midland, US

Key dates

• Filing date: Oct 11, 2018
• Grant date: Feb 4, 2025
• Expiry date: Mar 11, 2042

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a transdermal therapeutic system for the transdermal administration of guanfacine comprising a guanfacine-containing layer structure, said guanfacine-containing layer structure comprising: A) a backing layer; and B) a guanfacine-containing layer; wherein the transdermal therapeutic system comprises at least one polymer and at least additive.